A complementary drug to combat Alzheimer’s disease could target a specific part of the nerve cell protein tau. This is the finding of new research
Years before tau tangles show up in brain scans of patients with Alzheimer’s disease, a biomarker test can detect small amounts of the clumping-prone tau
A research team has discovered that the two key pathological hallmarks of Alzheimer’s — tau protein and beta-amyloid — affect brain circuits in distinct yet
New research has shown that diet could influence the risk of both depression and Alzheimer’s disease (AD). Evidence suggests that depressive symptoms are both a
A paradigm-shifting study shows an experimental drug, GL-II-73, has the potential to restore memory and cognitive function in a mouse model of Alzheimer’s disease. The